This invention includes oxazolidinone prodrug compounds of Formula (I) and Formula (II) as defined herein. The prodrugs are convertible by natural biological processes into an active ingredient possessed of antimicrobial properties useful in treating bacterial infections in mammals.
这项发明包括本文所定义的Formula (I)和Formula (II)的
噁唑烷酮前药化合物。这些前药可以通过自然
生物过程转化为一种具有抗微
生物特性的活性成分,可用于治疗哺乳动物体内的细菌感染。